Beacon Pointe Advisors, LLC Aquestive Therapeutics, Inc. Transaction History
Beacon Pointe Advisors, LLC
- $8.89 Billion
- Q4 2024
A detailed history of Beacon Pointe Advisors, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 60,000 shares of AQST stock, worth $192,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,000
Previous 60,000
-0.0%
Holding current value
$192,600
Previous $298,000
28.86%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
121Shares Held
43.3MCall Options Held
504KPut Options Held
148K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$31.5 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$17.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$14 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.63MShares$8.44 Million1.54% of portfolio
-
Franklin Resources Inc San Mateo, CA2.13MShares$6.85 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $171M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...